Background. Strategies for accelerated control of rubella and congenital rubella syndrome (CRS) in Chile included mass vaccination of women of childbearing age in 1999 but did not include vaccination of adult men.
Following on the success of measles elimination in the Americas in 2002 [1] , Chile adopted the goal of rubella and congenital rubella syndrome (CRS) elimination by 2010 with the other countries of the World Health Organization Region of the Americas. Prior to 1990, rubella cases had been steadily increasing in Chile, with epidemics occurring in cycles. In 1990, the Chilean national immunization program introduced routine immunization of children at 12 months of age with combined measles-mumps-rubella (MMR) vaccine, followed in 1991 by a recommendation for a second dose of vaccine at school entry. From 1990 through 1996, the incidence of rubella decreased rapidly (Figure 1 ), principally among children ,10 years old [2] . During 1997 and 1998, Chile experienced a resurgence of rubella cases throughout the country and a shift in the age distribution, with 70% of reported cases occurring among persons 10-29 years of age. Eighteen cases of CRS were identified following the rubella resurgence in 1997 and 1998.
To prevent additional cases of CRS, the Chilean Ministry of Health conducted a mass vaccination campaign targeting women 10-29 years of age in 1999, prior to implementation of a national plan for accelerated rubella control [3] . The campaign reached an estimated 99% of the target female population. Incidence of rubella and CRS cases decreased after the campaign. Rubella incidence was reduced from 31 cases per 100 000 population in 1998 to 11 cases per 100 000 population in 1999, followed by gradual decrease to 1.9 cases per 100 000 population in 2002 (a reduction of 94% compared with the incidence in 1998). In 2002, 68% of rubella cases occurred among children ,5 years of age. In 2003, only 128 confirmed rubella cases were identified in the country, for an incidence of 0.8 cases per 100 000 population, followed by 3 isolated rubella cases identified in 2004. In the same year, Chile integrated measles and rubella surveillance, and serum specimens from all suspected cases were tested at the national reference laboratory for evidence of measles and rubella virus infection.
Susceptibility to rubella persisted among groups of individuals, especially young male adults excluded from the mass vaccination campaign in 1999. From January through May 2005, an institutional outbreak of rubella (genotype 1C) was identified among naval recruits for a total of 46 cases. Then in March 2007, outbreaks caused by genotype 2B spread throughout Chile, resulting in .4000 cases over a 12-month period. This article describes the rubella outbreaks in 2005 and 2007 that affected the susceptible population, as well as the measures implemented in response to the outbreaks.
METHODS

Integrated Measles/Rubella Surveillance in Chile
Measles, rubella, and CRS are subject to mandatory notification according to national legislation (DS no. 158 of 2004 and DS no. 55 of 2008). A suspected case of measles was defined as a person presenting with fever, rash, and 1 respiratory symptom (cough, coryza, or conjunctivitis); suspicion of rubella was based on the clinician's criteria. When a patient presents for medical attention with symptoms compatible with suspected measles or rubella, the attending physician at the public or private health facility is responsible for immediately notifying the regional and national public health authorities of the suspected case, following established procedures. Until the first semester of 2003, Data from integrated measles/rubella notification forms were entered into the Measles Elimination Surveillance System (MESS; Pan American Health Organization, Washington, DC). Due to the rapid and unexpected increase in rubella cases during outbreaks in 2007, surveillance officers were unable to enter all cases in the MESS system created by the Pan American Health Organization for routine surveillance. During the outbreak period, spreadsheets were created in Microsoft Excel 2007 with the minimum number of variables sent by regional health departments to the central level.
Modified Surveillance Guidelines During 2007 Rubella Outbreaks
Following notification of the first suspected rubella cases in each outbreak, surveillance officers conducted active searches for additional rubella cases among contacts and vaccinated all of those without documented vaccination, including all contacts in academic or work settings. Serum specimens were collected from the first case patients identified in each outbreak setting or region, as the epidemic spread throughout Chile. Once 10% of the suspected rubella cases in each outbreak setting were confirmed by serological testing, collection of serum specimens was no longer recommended. Procedures for interpretation of serological test results followed the same algorithm used for integrated measles/rubella surveillance. In addition, at the beginning of the outbreak, nasopharyngeal aspirates were collected from suspected cases and inoculated in Vero cells for viral isolation and genotyping. Infection of Vero cells was confirmed using indirect immunofluorescence with rubella-specific monoclonal antibodies. Genotyping and nucleotide sequencing was performed at the ISP reference laboratory.
Case Definitions Used in 2007 Rubella Outbreaks
During rubella outbreaks from March through December 2007, a probable rubella case definition was adapted for surveillance purposes, defined as men $19 years old without recent history of travel outside Chile presenting with diffuse rash of acute onset and 1-3 days duration, with or without fever, and 1 or more of the following symptoms: arthralgia, arthritis, lymphadenopathy, or conjunctivitis. Regional health departments were instructed to test 10% of probable cases for laboratory evidence of rubella virus infection. Laboratory confirmation was required for all suspected cases of rubella in male or female individuals #18 years of age and in women $19 years of age. Epidemiological linkage was defined as exposure to a confirmed rubella case during the case patient's contagious period, defined as the 7 days before and after the date of rash onset. In institutional settings, the at-risk population was defined as men 19-29 years of age and women without documented rubella vaccination.
Analysis of Susceptible Birth Cohorts
Prior to the beginning of the rubella epidemic in 2007, the Department of Epidemiology in the Ministry of Health conducted a study of vaccination opportunities for male individuals according to year of birth to establish the target population for vaccination. The methodology used was similar to analyses conducted prior to the mass vaccination of women in 1999. The percentage of the population considered unprotected in each birth cohort was estimated as 100% minus the estimated vaccination coverage multiplied by the seroconversion rate (95%) for a single dose of vaccine. Cohorts that received 2 doses were assumed to be effectively immunized. To account for natural immunity as a result of infection among individuals , 30 years old, we calculated age-specific rubella incidence rates for the period 1990-2006 and subtracted from the unprotected population the number of rubella cases in each birth cohort. We assumed that 50% of rubella virus infections were asymptomatic and doubled the number of persons in each birth cohort assumed to have acquired national immunity. We assumed that 85% of adult men and women had naturally acquired rubellaspecific antibodies and considered all infants susceptible during their first year of life.
RESULTS
In 2005, 6 years after mass vaccination of women of childbearing age, a rubella outbreak was identified at the naval academy in Valparaíso, a city of 1.7 million inhabitants that receives large numbers of tourists situated to the north of the metropolitan region of Santiago. A total of 46 confirmed rubella cases were identified during the outbreak, all in men 18-22 years of age, 43 of whom were recruits at the naval academy and 3 of whom were university students with no epidemiologic link to the naval academy. Of the 46 confirmed cases, 35 (77%) were laboratoryconfirmed (including all 3 university students), whereas 11 (23%) were classified on the basis of clinical and epidemiologic criteria. Rubella virus genotype 1C was isolated from 2 case patients. Prompt notification of the first suspected rubella cases among naval recruits allowed rapid implementation of control measures at the naval academy; all recruits were vaccinated within 48 hours following confirmation of the outbreak. Additional measures included voluntary isolation of suspected cases during the contagious period and vaccination at other affected institutions. No additional cases were identified in the region or in other parts of Chile following the outbreak.
From March 2007 through February 2008, rubella outbreaks first detected in the metropolitan region of Santiago spread throughout Chile. A total of 4275 probable and confirmed rubella cases were reported (26 cases per 100 000 population). Among reported cases, 96% occurred in men with a median age of 23 years (range, 8 months-74 years). Incidence was highest among men 19-24 years old (259 cases per 100 000 population) ( Table 1 ). The epidemic curve demonstrates the rapid increase of rubella cases after epidemiologic week 25 (Figure 2 ), corresponding to the beginning of the winter period in Chile. The number of cases peaked during weeks 35-37 at the end of the winter period (late August to early September), with 300 new rubella cases reported weekly.
Rubella virus genotype 2B was isolated from nasopharyngeal samples submitted from 2 case patients in 2007. Nucleotide sequencing identified 99.8% similarity between rubella virus isolates in Chile and rubella genotype 2B viruses isolated from patients in Brazil and several European countries in 2007, suggesting probable importation into Chile of the genotype 2B rubella virus.
Rubella cases were reported from 14 of Chile's 15 regional departments. Cases were initially concentrated in the Santiago metropolitan region and Valparaíso (region V), but by week 23 cases were reported from Araucanía in the south and by week 27 from Antofagasta in the north of the country. Incidence of probable and confirmed rubella cases in the male population was highest in Antofagasta (68 cases per 100 000 male residents), Valparaíso (43 cases per 100 000 male residents), and the Santiago metropolitan region (41 cases per 100 000 male residents) (Figure 3 ). The only regional department that did not report cases was Aisén, possibly due to its geographic isolation and distance from Santiago. In addition, regional health authorities in Aisén received early warning of the rubella outbreaks in other regions.
Three children born with laboratory-confirmed CRS were identified in 2008; these were the first CRS cases identified in Chile since 2000. In only 1 case, the mother had been diagnosed with rubella during pregnancy, although the public health authorities had not been notified of the mother's infection at the time.
Description of Initial Cases and Control Measures
The first rubella case identified in 2007 occurred in a 23-year-old male postgraduate student residing in the metropolitan region with reported onset of rash, lymphadenopathy, and arthralgia on 21 March 2007; initial clinical suspicion was of an allergic reaction. Approximately 10 days later, the patient sought care for persistent symptoms at a second private health facility and serological testing for rubella was requested. Only after confirmation of rubella virus infection was the regional health secretariat notified by the private laboratory of the rubella case, at which time serum was sent to the national reference laboratory. On 13 April, 3 weeks after the case patient's onset of rash, the case was confirmed by the virology laboratory at the Public Health Institute. Contact tracing did not identify the case patient's source of infection. The case patient had traveled for vacation during the month of January to Brazil, where rubella outbreaks were reported in several states. By the time the index case had been notified to the surveillance system, a second rubella case was reported in a 24-year-old male resident in the metropolitan region; no epidemiologic link to the index case was established. This was followed by 2 additional cases in students (both male, 21 and 22 years old) at the same university although in different class years. Vaccination of students at the university was initiated for outbreak control. Clusters of rubella cases were subsequently reported from other institutions of higher education. At the end of May 2007, the first cases outside the metropolitan region were reported from Valparaíso (region V). Although contact tracing did not establish an epidemiologic link between the index case and subsequent cases, the epidemic curve suggests that initial cases occurred in 3 generations prior to widespread transmission (Figure 2) .
During case investigations and follow-up of the first rubella cases reported in the Santiago metropolitan region, vaccination with combined measles-rubella (MR) vaccine was offered to contacts as well as all persons working or studying in the same institution as suspected case patients. To improve early recognition and diagnosis of rubella for timely implementation of control measures, health alerts were sent through the surveillance departments to public and private health care facilities. Health professionals were reminded to notify the authorities of all suspected cases and collect serum samples and respiratory secretions for confirmatory testing. Surveillance personnel were instructed to thoroughly investigate confirmed cases to identify probable sources of infection and vaccinate contacts with MR vaccine. In regions that had not reported rubella cases, active case searches were conducted. By the peak of the outbreak in late August, a total of 350 confirmed rubella cases had been identified and .20 000 MR doses had been administered for outbreak control, increasing to 50 000 doses prior to initiation of a mass vaccination campaign targeted at men 19-29 years of age.
A study of rubella incidence and vaccination opportunities by birth cohort conducted in 
DISCUSSION
Persistence of susceptibility to rubella among young adult men created the conditions for a rubella outbreak and a rubella epidemic several years after mass vaccination of women of childbearing age in 1999. The rubella outbreak in 2005 mainly affected recruits at a naval academy and resulted in a limited number of cases. The rubella epidemic in 2007 resulted in a large number of cases, predominantly among men, and was characterized by rapid community and institutional dissemination from the capital of Santiago throughout the country. In the 2005 rubella outbreak among naval recruits, timely notification and implementation of control measures may have limited transmission and helped control the outbreak. Vaccination of contacts was initiated a short time after exposure to infectious cases, reducing transmission inside the naval academy as well as in the community. However, the identification of 3 cases among university students not associated with the naval academy suggests that community transmission did occur and might have resulted in a much larger outbreak. In contrast, delayed diagnosis and laboratory confirmation of the index case in 2007 may have contributed to community transmission prior to implementation of control measures, with rapid dissemination among susceptible young adults. Ring vaccination of contacts in the community and institutions was ineffective in preventing the rubella epidemic. In contrast to the outbreak among naval recruits, other control measures such as voluntary quarantine during the infectious period were not feasible and young adults with rubella circulated widely.
Prior to the outbreak, control activities, including vaccination of contacts, were not initiated until after rubella was confirmed as the cause of illness. Despite the integration of measles and rubella surveillance, vaccination with MR vaccine was only recommended after notification of suspected measles cases, whereas for suspected rubella cases, laboratory confirmation was required. As of 2010, ring vaccination with MR vaccine was initiated upon notification of suspected rubella or measles.
A tragic consequence of the rubella epidemic was the occurrence of 3 cases of CRS in children born to women presumably infected during the beginning of their pregnancies. This not only was a setback for Chile's CRS elimination goals but also indicated susceptibility to rubella infection among some percentage, however small, of women of childbearing age. This observation served as additional justification for the implementation of the mass vaccination of adult male individuals to achieve elimination goals for rubella and CRS in Chile [4] .
Chile maintains a network of epidemiologic surveillance at all levels in the health system, including public and private institutions. Delayed diagnosis and notification of febrile rash illnesses may result from low indices of suspicion for diseases in phases of elimination such as measles and rubella. On the other hand, the national reference laboratory at the Public Health Institute has gained experience with viral isolation from clinical specimens and genotyping, first with measles viruses and more recently with rubella viruses, which will be needed for characterization of imported cases. Characterization of rubella virus isolates worldwide is still limited. In Chile, only 3 rubella virus genotypes have been identified: 1E (during an outbreak in 1998-1999), 1C (2005 outbreak), and 2B (2007 epidemic).
Genotype 2B was not detected in the Americas prior to 2006 and, based on sequence information, may represent an importation from Europe, which is considered to be endemic for the genotype [5] . The detection of genotype 2B in Chile coincided with rubella outbreaks in Brazil and Argentina from 2006 through 2009. Notably, all 3 countries had conducted mass vaccination of women of childbearing age to accelerate control of CRS but had not vaccinated adult men, which suggests that vaccination strategies for rubella elimination should include male and female individuals. The last cases of infection with genotype 2B rubella virus were identified in northern Argentina in the first semester of 2009 and represented the last endemic cases of rubella in the Region of the Americas.
Chile is preparing documentation to verify the elimination of endemic measles, rubella, and CRS by 2012. To maintain the elimination of measles and rubella in Chile, as well as throughout the region, high routine coverage with MMR vaccine needs to be maintained and imported cases need to be detected and notified promptly to prevent secondary transmission. Maintaining sensitivity of integrated surveillance for measles and rubella and laboratory expertise to rapidly characterize imported viruses are essential due to the constant risk of importation from endemic regions.
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